Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 1.508\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a. CC(=C1C(=O)c2ccccc2C1=O)N1CCN(C/C=C/c2ccccc2)CC1
b. Cc1ccc(C(=O)N=c2sccn2C)cc1S(=O)(=O)N1CCOCC1
c. O=C(NCc1ccccc1)C1CCCN(S(=O)(=O)c2ccc(-n3cnnn3)cc2)C1
Answer: b. Cc1ccc(C(=O)N=c2sccn2C)cc1S(=O)(=O)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C(=O)N=c2sccn2C)cc1S(=O)(=O)N1CCOCC1
Cc1ccc(C(=O)N=c2sccn2C)cc1S(=O)(=O)N1CCOCC1
4-methyl-N-(3-methyl-1,3-thiazol-2-ylidene)-3-morpholin-4-ylsulfonylbenzamide